These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4646277)

  • 1. The action of L(-)-dopa on baroreflexes in Parkinsonism.
    Reid JL; Calne DB; George CF; Vakil SD
    Clin Sci; 1972 Dec; 43(6):851-9. PubMed ID: 4646277
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of L- -methyldopa-hydrazine on the blood pressure of patients receiving levodopa.
    Calne DB; Petrie A; Rao S; Reid JL; Vakil SD
    Br J Pharmacol; 1972 Jan; 44(1):162-4. PubMed ID: 5015036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and late effects of levodopa on the cardiovascular system in Parkinson's disease. A paired study.
    Ballantyne JP
    J Neurol Sci; 1973 May; 19(1):97-103. PubMed ID: 4715025
    [No Abstract]   [Full Text] [Related]  

  • 4. Levodopa in the treatment of Parkinsonism.
    Cotzias GC
    JAMA; 1971 Dec; 218(13):1903-8. PubMed ID: 5171066
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of L-dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes.
    Watanabe AM; Chase TN; Cardon PV
    Clin Pharmacol Ther; 1970; 11(5):740-6. PubMed ID: 5455636
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Parkinsonism with L-dopa and decarboxylase inhibitors. An electrophysiological study.
    Dietrichson P
    Acta Neurol Scand Suppl; 1972; 51():111-3. PubMed ID: 4514333
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in baroreflexes induced by L-dopa.
    Calne DB; George CF; Reid JL; Vakil SD
    Br J Pharmacol; 1972 Nov; 46(3):539P. PubMed ID: 4656624
    [No Abstract]   [Full Text] [Related]  

  • 8. On the mechanism of L-dopa-induced postural hypotension in the cat.
    Dhasmana KM; Spilker BA
    Br J Pharmacol; 1973 Mar; 47(3):437-51. PubMed ID: 4147189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa and pressor amine sensitivity in parkinsonism.
    Reid JL; Calne DB; George CF; Vakil SD
    Clin Pharmacol Ther; 1972; 13(3):400-6. PubMed ID: 5026378
    [No Abstract]   [Full Text] [Related]  

  • 10. Action of levodopa on the blood pressure of conscious rabbits.
    Calne DB; Reid JL
    Clin Sci; 1973 Apr; 44(4):18P. PubMed ID: 4699305
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma testosterone content of male patients with Parkinson's disease during L-dopa treatment with or without dopadecarboxylase inhibitor.
    Pekkarinen A; Rinne UK; Salokangas R; Siirtola T; Sonninen V
    Acta Neurol Scand Suppl; 1972; 51():129-30. PubMed ID: 4514339
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiovascular reflex activity in Parkinsonism.
    Reid JL; Calne DB; George CF; Vakil SD
    Clin Sci; 1971 Feb; 40(2):6P-7P. PubMed ID: 5548537
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602).
    Holmsen R; Kvan L; Presthus J; Thoresen GB
    Acta Neurol Scand Suppl; 1972; 51():121-2. PubMed ID: 4514336
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of various agents on the pressor response to dopa in the anesthetized dog.
    Pruss TP; McGill JS
    Eur J Pharmacol; 1969 Oct; 8(1):14-8. PubMed ID: 4391043
    [No Abstract]   [Full Text] [Related]  

  • 15. Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.
    Calne DB; Reid JL; Vakil SD; Rao S; Petrie A; Pallis CA; Gawler J; Thomas PK; Hilson A
    Br Med J; 1971 Sep; 3(5777):729-32. PubMed ID: 4938431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study].
    Wälzholz U; Schönfelder H
    Nervenarzt; 1972 Oct; 43(10):531-2. PubMed ID: 4628192
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of catechol-O-methyl transferase by L-dopa and decarboxylase inhibitors.
    Baldessarini RJ
    J Pharm Pharmacol; 1972 Jan; 24(1):78-80. PubMed ID: 4401326
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of L-dopa on postural reflexes in Parkinson's disease.
    Chaco J; Abramsky O
    Z Neurol; 1971; 200(2):122-5. PubMed ID: 4108115
    [No Abstract]   [Full Text] [Related]  

  • 19. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR; Messiha FS; Hsu TH
    Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of vitamin B6 to reverse the L-dopa effect in patients on a dopa decarboxylase inhibitor.
    Klawans HL; Ringel SP; Shenker DM
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):682-6. PubMed ID: 5158783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.